Joel McKinnon Miller

Ask VT AI
View News Summary
  • Congressman's remarks on SNAP benefits spark outrage, as critics argue his claims are misleading and perpetuate harmful stereotypes.
  • Eli Lilly to acquire Adverum Biotechnologies in a deal worth up to $12.47 per share, with a focus on Adverum's gene therapy candidate Ixo-vec.
  • Typhoon Halong devastates Alaska, leaving thousands displaced and homes destroyed in a harrowing ordeal for one resident.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Congressman's remarks on SNAP benefits spark outrage, as critics argue his claims are misleading and perpetuate harmful stereotypes.
  • Eli Lilly to acquire Adverum Biotechnologies in a deal worth up to $12.47 per share, with a focus on Adverum's gene therapy candidate Ixo-vec.
  • Typhoon Halong devastates Alaska, leaving thousands displaced and homes destroyed in a harrowing ordeal for one resident.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Joel McKinnon Miller